Ceeto Capital Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,000
Closed -$32K 188
2025
Q1
$32K Hold
4,000
0.01% 178
2024
Q4
$36K Sell
4,000
-19,500
-83% -$188K 0.01% 178
2024
Q3
$216K Hold
23,500
0.08% 147
2024
Q2
$230K Hold
23,500
0.09% 137
2024
Q1
$355K Hold
23,500
0.15% 123
2023
Q4
$506K Hold
23,500
0.22% 95
2023
Q3
$437K Hold
23,500
0.21% 103
2023
Q2
$595K Hold
23,500
0.27% 80
2023
Q1
$609K Hold
23,500
0.3% 75
2022
Q4
$556K Buy
+23,500
New +$634K 0.31% 77
2022
Q3
Sell
-7,250
Closed -$241K 163
2022
Q2
$241K Hold
7,250
0.13% 131
2022
Q1
$523K Hold
7,250
0.24% 100
2021
Q4
$666K Sell
7,250
-750
-9% -$89.6K 0.28% 81
2021
Q3
$1.01M Hold
8,000
0.47% 57
2021
Q2
$1.33M Buy
8,000
+250
+3% +$40.5K 0.6% 49
2021
Q1
$1.41M Buy
7,750
+150
+2% +$34.8K 0.69% 43
2020
Q4
$1.52M Hold
7,600
0.77% 38
2020
Q3
$1.67M Sell
7,600
-500
-6% -$106K 0.93% 25
2020
Q2
$1.55M Hold
8,100
1% 27
2020
Q1
$1.26M Sell
8,100
-500
-6% -$58.2K 1.01% 27
2019
Q4
$720K Hold
8,600
0.47% 64
2019
Q3
$582K Hold
8,600
0.42% 71
2019
Q2
$571K Buy
+8,600
New +$501K 0.42% 71

Other funds holding TDOC

Ceeto Capital Group's TDOC Position: Q2 2025 in Review

Ceeto Capital Group sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 4,000 shares — an estimated $32K sold.

Ceeto Capital Group first reported a position in TDOC in Q2 2019 and held it in 23 quarters. The position peaked at $1.67M in Q3 2020. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Ceeto Capital Group reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Ceeto Capital Group sold 4,000 Teladoc Health shares in Q2 2025, an estimated $32K.
  • Ceeto Capital Group first reported a position in Teladoc Health in Q2 2019 and held it in 23 quarters.
  • Ceeto Capital Group's Teladoc Health position peaked at $1.67M in Q3 2020.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Ceeto Capital Group's 13F filing for Q2 2025, filed 14 Aug 2025.